SBIR/STTR Research Award

Development of biopsy devices for improved preservation of multiple biopsy tissue samples

Award identifier 7933d5c13efb99db93cca15f938ab94aa5fcd788d9cee04d36d510876c3132e5Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$225,000

Program and phase

SBIR · Phase I

Award year

2017

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
ROBIN MEDICAL INC
Proposal award date
2017-09-15
Contract end date
2018-12-31
UEI
S38NM2MSMM14
Solicitation number
ES16-012
Topic code
113

Research abstract

Project Summary Molecular medicine holds promise for advancing medical diagnosis and treatment if biomarkers can be accurately assessed in tissues for example in tumors The long term objective of the project is to bring to market new tools for better biopsy tissue acquisition processing and storing A first new biopsy device aims to acquire multiple samples into a cartridge and to stabilize the biopsy tissue samples shortly after they are cut for example by freezing and thus prevent changes in biomarker levels due to ischemia in the excised tissue samples A second new biopsy device aims to split the tissue samples into two parts to store one part in a way that will optimally maintain the histology of the tissue e g formalin fixation and the second part in a way that will optimally maintain the biomarker levels in the tissue e g freezing The specific aims of this Phase I project are to develop a prototype core biopsy device for sequential multiple samples acquisition through a single needle insertion to develop vacuum assisted biopsy device with dual mode preservation for short term storage of the tissue samples and to compare histology sections and biomarkers qualities as achieved by the prototype biopsy devices versus clinical grade biopsy device A biopsy methodology that preserves the tissue morphology and stabilizes the biomolecular profile of the cells in the biopsy samples is expected to be used for many clinical and research applications and to achieve wide commercial market In particular such a device can be used to monitor the effect of targeted treatment and to improve the management of patients by the use of individualized therapy that targets the specific characteristics of the diseased tissue in each patient Narrative The development of new methodology and devices for better acquisition and handling of biopsy tissue samples will facilitate the use of new diagnostic tests and the development of method to adapt and optimize therapy to the individual patient

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

24 SBIR/STTR records share this UEI (1998–2020). Reported award amounts total $18,932,366. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.